Gastrointestinal bleeding in cardiac patients: epidemiology and evolving clinical paradigms

Area of Science:

• Cardiology
• Gastroenterology
• Clinical Medicine

Background:

• Cardiac patients frequently use antithrombotic medications, increasing their vulnerability to gastrointestinal bleeding (GIB).
• The aging American population and increased use of anticoagulants and antiplatelets contribute to a rising incidence of GIB.
• Emerging evidence indicates a significant and clinically relevant risk of GIB in patients with cardiac conditions.

Purpose of the Study:

• To quantify the gastrointestinal bleeding risk in cardiac patients prescribed antithrombotic medications.
• To summarize current risk-management strategies for preventing GIB in this population.
• To identify knowledge gaps in understanding and managing GIB in cardiac patients.

Main Methods:

• Literature review to synthesize existing evidence on GIB risk in cardiac patients.
• Analysis of epidemiological trends in GIB related to cardiac disease and antithrombotic use.
• Exploration of multidisciplinary approaches involving cardiologists and gastroenterologists.

Main Results:

• The incidence of upper and lower GIB is expected to increase due to an aging population and higher comorbidity burden.
• New evidence confirms a substantial and clinically significant GIB risk associated with antithrombotic therapies.
• The evolving landscape of antiplatelet and anticoagulant use necessitates a re-evaluation of GIB epidemiology.

Conclusions:

• The extent of gastrointestinal risk in cardiac patients remains underexplored due to limited literature.
• A multidisciplinary approach, including patient participation and collaboration between cardiologists and gastroenterologists, is crucial.
• Further research is needed to address knowledge gaps and refine risk-minimization strategies for GIB in cardiac patients.